NASDAQ:GRCL
Gracell Biotechnologies Inc.
- Stock
Last Close
10.24
21/02 21:00
Market Cap
965.02M
Beta: −1.83
Volume Today
6.37M
Avg: 131.30K
PE Ratio
−12.25
PFCF: -
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|---|
net income | -60.79M - | -138.66M 128.09% | -211.90M 52.82% | -451.75M 113.19% | -607.51M 34.48% | |
depreciation and amortization | 2.99M - | 5.12M 71.26% | 21.59M 321.33% | 60.27M 179.16% | 77.51M 28.61% | |
deferred income tax | ||||||
stock based compensation | 60.38M - | 24.10M 60.09% | ||||
change in working capital | -4.05M - | 703K 117.34% | -10.75M 1,629.45% | 25.26M 334.90% | 15.08M 40.28% | |
accounts receivables | ||||||
inventory | ||||||
accounts payables | ||||||
other working capital | ||||||
other non cash items | -2.56M - | 2.91M 214.01% | 1.30M 55.49% | 8.17M 529.84% | ||
net cash provided by operating activities | -61.86M - | -135.39M 118.88% | -198.15M 46.35% | -304.55M 53.70% | -482.65M 58.48% | |
investments in property plant and equipment | -11.36M - | -56.43M 396.89% | -79.40M 40.70% | -56.74M 28.54% | -48.39M 14.72% | |
acquisitions net | -97.80K - | 28.05M 28,786.09% | 10M 64.36% | 261.17M 2,511.66% | ||
purchases of investments | -335M - | -80.20M 76.06% | -28.05M 65.02% | -10M 64.36% | -261.17M 2,511.66% | |
sales maturities of investments | 233M - | 178M 23.61% | 13.51M 92.41% | 25.13M 85.93% | 261.22M 939.61% | |
other investing activites | 97.80K - | -28.05M 28,786.09% | -10M 64.36% | -261.17M 2,511.66% | ||
net cash used for investing activites | -113.36M - | 41.37M 136.49% | -93.94M 327.09% | -41.62M 55.70% | -48.33M 16.14% | |
debt repayment | -10M - | -138.82M - | -51.29M 63.05% | -68.48M 33.50% | ||
common stock issued | 1.45B - | |||||
common stock repurchased | -44.70M - | |||||
dividends paid | ||||||
other financing activites | 148.69M - | 439.50M 195.57% | 895.28M 103.70% | 58.52M 93.46% | 101.80M 73.96% | |
net cash used provided by financing activities | 138.69M - | 394.80M 184.65% | 756.47M 91.61% | 1.46B 92.50% | 33.32M 97.71% | |
effect of forex changes on cash | -603K - | -22.13M 3,569.49% | -35.32M 59.63% | 123.30M 449.07% | ||
net change in cash | -36.52M - | 300.17M 921.97% | 442.25M 47.33% | 1.07B 143.01% | -374.36M 134.83% | |
cash at beginning of period | 48.41M - | 11.89M 75.44% | 312.06M 2,524.54% | 754.31M 141.72% | 1.83B 142.47% | |
cash at end of period | 11.89M - | 312.06M 2,524.54% | 754.31M 141.72% | 1.83B 142.47% | 1.45B 20.47% | |
operating cash flow | -61.86M - | -135.39M 118.88% | -198.15M 46.35% | -304.55M 53.70% | -482.65M 58.48% | |
capital expenditure | -11.36M - | -56.43M 396.89% | -79.40M 40.70% | -56.74M 28.54% | -48.39M 14.72% | |
free cash flow | -73.21M - | -191.82M 162.01% | -277.55M 44.69% | -361.29M 30.17% | -531.04M 46.98% |
All numbers in USD (except ratios and percentages)